--- title: "Resources" description: "Guides, insights, and documentation for life science research teams." url: https://amass.tech/resources --- # Resources Resources # Guides, insights, and documentation Guides and API references for getting more out of Amass, and a newsletter on life science research intelligence. [API overview →](https://platform.amass.tech/documentation/getting-started/overview)[BioMedCore reference →](https://platform.amass.tech/documentation/cores/biomedcore)[TrialCore reference →](https://platform.amass.tech/documentation/cores/trialcore)[Quickstart →](https://platform.amass.tech/documentation/getting-started/quickstart)[Events & webinars →](https://amass.tech/events) 22 articles[Webinars and recordings live under Events →](https://amass.tech/events) [ NewsFeatured ## Amass and SciSure partner to bring scientific AI into laboratory workflows worldwide The partnership connects Amass scientific intelligence with SciSure serving more than 550,000 scientists, EHS and LabOps users across 55,000 laboratories worldwide. Read article →Oct 2026 · 3 min read ](https://amass.tech/resources/amass-scisure-integration) [ ### What two winning teams built on Amass at HACK\_002 in Vienna On 26 and 27 September, Amass was a partner of HACK\_002: Signal From Tomorrow in Vienna. Around 65 people, 25 teams and 19.5 hours Here is what two of the winning teams built on Amass Oct 20262 min read ](https://amass.tech/resources/vienna-hack-002-signal-from-tomorrow)[ Customer ### From cycle tracking to action: how Gina won its track in Vienna Solo founder PJ Vang won the Applied AI for You track at HACK\_002 in Vienna with Gina, a cycle app whose agents rank symptom relief by published evidence. Oct 20266 min read ](https://amass.tech/resources/gina-cycle-symptom-evidence)[ Customer ### A source for every claim: how GenCite won the Scientific Discovery track in Vienna GenCite turns a gene list into short claims, each citing the evidence behind it and checked twice. A team of two built it on Amass in 19.5 hours in Vienna. Oct 20264 min read ](https://amass.tech/resources/gencite-gene-list-evidence)[ Amass · Resource The right pill at the right time: how LockedIn won the Stockholm hackathon Use Case ### The right pill at the right time: how LockedIn won the Stockholm hackathon Team LockedIn won the Stockholm Longevity × AI Hackathon with Pillot, a voice-guided medication companion that backs family questions with research via Amass. Oct 20264 min read ](https://amass.tech/resources/lockedin-pillot-stockholm-hackathon)[ Amass · Resource Every FDA and EMA Authorization for One Substance Use Case ### Every FDA and EMA Authorization for One Substance Semaglutide holds ten FDA and EMA authorizations under five invented names. RegulatoryCore returns all ten from one search on the substance. Oct 202612 min read ](https://amass.tech/resources/every-fda-and-ema-authorization-for-one-substance)[ ### What the Stockholm Longevity × AI Hackathon taught us about building for researchers 3 weeks ago, Amass joined the Stockholm Longevity × AI Hackathon. 80+ participants, 16 teams and 5 tracks Here is what the winners built and what we learned Oct 20263 min read ](https://amass.tech/resources/stockholm-longevity-ai-hackathon)[ News ### Amass brings scientific intelligence infrastructure to Microsoft Copilot New integration connects Amass’ scientific intelligence infrastructure with Microsoft Copilot, bringing interconnected life science knowledge directly into the everyday workflows of scientists and life science organizations. Sep 20265 min read ](https://amass.tech/resources/amass-microsoft-copilot)[ Amass · Resource CDH17 at AACR and ASCO 2026: 26 molecules and one journal paper with patients Use Case ### CDH17 at AACR and ASCO 2026: 26 molecules and one journal paper with patients BiomedCore now includes conference abstracts. For CDH17, the AACR and ASCO 2026 abstracts list 26 molecules, and the journals hold one paper with patients. Sep 202610 min read ](https://amass.tech/resources/cdh17-aacr-asco-2026-conference-abstracts)[ Product ### The new Amass app is live The largest update to Amass since the app first launched. Ask across all eight \*Cores, steer the research as it runs and trace every claim to its source. Sep 20267 min read ](https://amass.tech/resources/the-new-amass-app-is-live)[ News ### Amass × BASE life science: taking scientific AI to enterprise scale Amass and BASE life science are partnering to take scientific AI from individual use cases to enterprise-scale implementation in life sciences. Aug 20262 min read ](https://amass.tech/resources/amass-base-life-science-partnership)[ Customer ### Killing drug targets early: how Apoptosis AI won the London hackathon Two winning teams from the London "Building an AI Scientist" hackathon built on the Amass Cores, and both were still building on them more than a month later. Here is what they built and why they reached for a curated, linked data instead of a search tool. Aug 202611 min read ](https://amass.tech/resources/apoptosis-ai-target-assessment)[ ### What the Building an AI Scientist London Hackathon taught us about Tech x Bio What we learned from 50 builders and what it taught us about building successfully in Tech x Bio. Jul 20265 min read ](https://amass.tech/resources/building-ai-scientist-tech-x-bio)[ Amass · Resource From molecule to market: introducing DrugCore and RegulatoryCore ### From molecule to market: introducing DrugCore and RegulatoryCore Introducing DrugCore and RegulatoryCore: drugs and FDA/EMA approvals, harmonized and linked to the trials and literature you already query. Jun 20267 min read ](https://amass.tech/resources/introducing-drugcore-regulatorycore)[ Technical ### Introducing GeneCore: One Link From a Drug to Its Target Biology Introducing GeneCore, one canonical record per gene, plus mechanism of action on every DrugCore record. See how the two connect a drug to its target biology in a single API link. May 20267 min read ](https://amass.tech/resources/introducing-genecore-mechanism-of-action)[ Amass · Resource Eval First, Model Second: Inside the TrialCore Iteration Loop Technical ### Eval First, Model Second: Inside the TrialCore Iteration Loop A look at the evaluation infrastructure behind one of Amass's core retrieval services. How we build the datasets, why we trust the labels, and the loop we run to actually move metrics. May 20269 min read ](https://amass.tech/resources/eval-first-model-second-trialcore-iteration-loop)[ Technical ### Comparing 4 biomedical MCPs using a fixed agent harness Aggregate results and a worked NSCLC case study from a four-server biomedical MCP benchmark (Amass, PubMed, Consensus, Paperclip). May 202613 min read ](https://amass.tech/resources/comparing-4-biomedical-mcps-claude-code)[ Product ### Why biomedical AI fails at retrieval before it fails at reasoning A 10-question benchmark across Amass BioMedCore, Claude with PubMed, and ChatGPT with web search. Retrieval, not reasoning, is biomedical AI's bottleneck. Apr 202612 min read ](https://amass.tech/resources/why-biomedical-ai-fails-at-retrieval)[ Product ### Monitor description and examples Mar 20261 min read ](https://amass.tech/resources/monitor-description-and-examples)[ Product ### Introducing Planner: A New Way to Guide Your Research Mar 20262 min read ](https://amass.tech/resources/introducing-planner-a-new-way-to-guide-your-research)[ Product ### Introducing \*Core: The Intelligence Architecture Behind Amass All six external data sources are being renamed to a unified \*Core naming convention — BioMedCore, ScholarCore, PatentCore, RegulatoryCore, TrialCore, and… Mar 20263 min read ](https://amass.tech/resources/introducing-core-the-intelligence-architecture-behind-amass)[ Product ### Global Data Context and Placeholder Positioning Enhanced accessibility and configurability of report placeholders and global data context in the Amass platform improve user experience. Feb 20262 min read ](https://amass.tech/resources/global-data-context-and-placeholder-positioning) ## Subscribe to the Amass newsletter Life science intelligence, product updates, and research trends, in your inbox twice a month. No spam. Unsubscribe anytime. We don't share your email. ## Building on the API? Full API documentation and reference at platform.amass.tech [Go to docs →](https://platform.amass.tech/documentation/getting-started/overview)[API overview](https://amass.tech/life-science-api) Data No training on your data Hosting EU-hosted, enterprise Isolation Tenant-isolated by architecture Certification ISO 27001, SOC 2, NIS2: in motion